A gluten-free vanilla cake offers a lighter alternative for those who avoid wheat or prefer experimenting with new ingredients. This cake uses flours like rice, almond, or oat, which naturally create a soft texture without the need for gluten. With the right mix
As wellness trends go upscale, Nestle's mass-market vitamins lose some shine
Nestle is looking to exit its mass-market vitamin business. However, consumers are increasingly preferring expensive, science-backed supplements. This trend complicates Nestle's sale efforts. Industry rivals show little interest, but private equity funds might step in.
Nestle wants out of mass-market vitamins. But a move by consumers towards more expensive, science-backed products risks complicating the Swiss conglomerate's effort to fetch a high price for its underperforming brands.
The $250 billion consumer food giant said in July it was launching a strategic review of low-growth, low-margin brands in the vitamins, minerals and supplements category, a prelude to a possible sale reconfirmed by Nestle after new CEO Philipp Navratil took the helm in September.
However, consumers in the $193 billion global supplement market
Furthermore, the supplement market is fragmented, and its regulatory landscape is in flux, adding risk to any acquisition. Industry players are signaling disinterest, Reuters' reporting found - but private equity funds are more likely to be in play.
PRIVATE EQUITY COULD MAKE A PLAY
Nestle acquired these vitamin brands in 2021 for — the third-largest acquisition in the vitamin, mineral and supplement space in at least the last 12 years, according to data from PitchBook.Matching those valuations will be a tall order amid a "huge wave" of interest by consumers in brands whose product claims have been rigorously tested in clinical settings
Industry rivals like Danone and Unilever are signaling a preference for higher-end brands with clear growth potential.
A senior source at Unilever, while stopping short of fully dismissing a deal for Nestle's brands, said any acquisitions the company makes must be of science and tech-led brands in fast-growing sectors.
Return on investment is also uncertain in a highly fragmented industry, said Mintel analyst David Hamlette. None of the brands Nestle may sell owns more than 2.1% of the U.S. vitamin market, according to share data from Euromonitor International.
The future of the US regulatory landscape is another wild card: in March, U.S. Health Secretary Robert F. Kennedy, Jr., announced he wants to tighten a federal approval process for new food additives known as the "Generally Regarded as Safe" pathway, or GRAS- a move that, if finalized, could increase scrutiny of new ingredientshas not officially proposed the rule change, though industry observers expect one soon. A public comment period would follow.
The proposal would make it harder for companies to market new food additives without U.S. Food and Drug Administration review, fetching opposition from the Council for Responsible Nutrition, a supplement industry trade group. A better solution is "to provide FDA with the resources" to enforce current rules, said Andrea Wong, CRN's senior vice president of scientific and regulatory affairs.
In a statement, an HHS spokesperson said tightening GRAS would "ultimately benefit the dietary supplement marketplace, along with conventional foods, by making both safer."
The disinclination toward Nestle's mass-market vitamins went beyond direct competitors in the packaged goods space.
GNC, a supplement retailer that also sells its own brands, said it was focused on innovating within its own portfolio, and on brands "that align with our science-backed standards," CEO Michael Costello told Reuters on October 31.
Yet the potential upside remains significant: the global dietary supplement market, pegged at $192.7 billion in 2024, is forecast to explode to $414.5 billion by 2033, according to market research firm Grand View. Such growth prospects may entice buyout funds, said Alex Evans, a partner at L.E.K. Consulting who leads the firm's health & wellness practice. These players would, however, drive a hard bargain, as they would not be able to generate the same cost savings of an industry player. "Private equity seems to be the most likely option, and yes — valuations might suffer," said Kai Lehmann, portfolio manager at Nestle stockholder Flossbach von Storch.
Add as a Reliable and Trusted News Source Add Now!
Source: EconomicTimes
Related Posts: Nestle recalls some of its baby formulas Nestlé CEO apologises over instant formula recall Nestlé explores sale of Blue Bottle Coffee UAE recalls some Nestle infant formula products Nestle Q3 results Nestle to axe 16 Nestle's new CEO faces full plate of problems Udit Narayan's first wife claims he 'got her uterus removed without consent' Chennai Comic Con 2026 Osaka copies Ronaldo during during press con
A gluten-free vanilla cake offers a lighter alternative for those who avoid wheat or prefer experimenting with new ingredients. This cake uses flours like rice, almond, or oat, which naturally create a soft texture without the need for gluten. With the right mix
3 months ago
